Stocks · News reference
RBC Capital Markets Raises Price Target on Doximity
RBC Capital Markets increased its price target for Doximity, Inc. (NYSE: DOCS) from $28 to $34 while maintaining an "Outperform" rating.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Doximity Expands AI Tools and Reports Growth in AI Search Advertising
Doximity is expanding its AI-driven clinical tools and advertising business, reporting significant growth in health system adoption and bookings for its AI Search advertising product.
Doximity, Inc. Reports Second-Quarter Revenue Beat
Doximity, Inc. announced its second-quarter financial results, reporting revenue of $174.54 million, which exceeded analyst expectations.
RBC Capital Maintains Outperform on Doximity, Raises Price Target to $34
Evercore ISI Group Maintains In-Line on Doximity, Lowers Price Target to $33
Dr. Martens plc Admits Additional Shares to Trading
Dr. Martens plc has admitted 94,286 new ordinary shares to the London Stock Exchange Main Market in connection with employee share schemes.